[Radiologic Evaluation for Resectability of Pancreatic Adenocarcinoma].
Shin Hye HwangChang Moo KangPublished in: Taehan Yongsang Uihakhoe chi (2021)
Imaging studies play an important role in the detection, diagnosis, assessment of resectability, staging, and determination of patient-tailored treatment options for pancreatic adenocarcinoma. Recently, for patients diagnosed with borderline resectable or locally advanced pancreatic cancers, it is recommended to consider curative-intent surgery following neoadjuvant or palliative therapy, if possible. This review covers how to interpret imaging tests and what to consider when assessing resectability, diagnosing distant metastasis, and re-assessing the resectability of pancreatic cancer after neoadjuvant or palliative therapy.
Keyphrases
- locally advanced
- rectal cancer
- lymph node
- neoadjuvant chemotherapy
- squamous cell carcinoma
- high resolution
- phase ii study
- radiation therapy
- end stage renal disease
- ejection fraction
- minimally invasive
- prognostic factors
- palliative care
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- young adults
- patient reported outcomes
- replacement therapy
- mass spectrometry
- real time pcr
- mesenchymal stem cells
- study protocol
- patient reported